These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 22074433)

  • 1. Liver enzymes: potential cardiovascular risk markers?
    Lioudaki E; Ganotakis ES; Mikhailidis DP
    Curr Pharm Des; 2011 Nov; 17(33):3632-43. PubMed ID: 22074433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aminotransferase and gamma-glutamyltranspeptidase levels in obesity are associated with insulin resistance and the metabolic syndrome.
    Marchesini G; Avagnina S; Barantani EG; Ciccarone AM; Corica F; Dall'Aglio E; Dalle Grave R; Morpurgo PS; Tomasi F; Vitacolonna E
    J Endocrinol Invest; 2005 Apr; 28(4):333-9. PubMed ID: 15966506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex influenced association of directly measured insulin sensitivity and serum transaminase levels: Why alanine aminotransferase only predicts cardiovascular risk in men?
    Buday B; Pach PF; Literati-Nagy B; Vitai M; Kovacs G; Vecsei Z; Koranyi L; Lengyel C
    Cardiovasc Diabetol; 2015 May; 14():55. PubMed ID: 25986611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positive correlations of liver enzymes with metabolic syndrome including insulin resistance in newly diagnosed type 2 diabetes mellitus.
    Zhang Y; Lu X; Hong J; Chao M; Gu W; Wang W; Ning G
    Endocrine; 2010 Oct; 38(2):181-7. PubMed ID: 20972737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis.
    Ballestri S; Zona S; Targher G; Romagnoli D; Baldelli E; Nascimbeni F; Roverato A; Guaraldi G; Lonardo A
    J Gastroenterol Hepatol; 2016 May; 31(5):936-44. PubMed ID: 26667191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Relationship Between Liver Enzymes and Insulin Resistance in Type 2 Diabetes Patients with Nonalcoholic Fatty Liver Disease.
    Sheng X; Che H; Ji Q; Yang F; Lv J; Wang Y; Xian H; Wang L
    Horm Metab Res; 2018 May; 50(5):397-402. PubMed ID: 29723898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver enzymes, the metabolic syndrome, and incident diabetes: the Mexico City diabetes study.
    Nannipieri M; Gonzales C; Baldi S; Posadas R; Williams K; Haffner SM; Stern MP; Ferrannini E;
    Diabetes Care; 2005 Jul; 28(7):1757-62. PubMed ID: 15983331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin resistance and metabolic syndrome in patients with NAFLD but without diabetes: effect of a 6 month regime intervention.
    Cankurtaran M; Tayfur O; Yavuz BB; Geyik S; Akhan O; Arslan S
    Acta Gastroenterol Belg; 2007; 70(3):253-9. PubMed ID: 18074733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical correlates of persistently elevated liver enzymes in type 2 diabetic outpatients.
    Giandalia A; Romeo EL; Ruffo MC; Muscianisi M; Giorgianni L; Forte F; Cucinotta D; Russo GT
    Prim Care Diabetes; 2017 Jun; 11(3):226-232. PubMed ID: 28017576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phospholipid transfer protein activity is determined by type 2 diabetes mellitus and metabolic syndrome, and is positively associated with serum transaminases.
    Dullaart RP; de Vries R; Dallinga-Thie GM; Sluiter WJ; van Tol A
    Clin Endocrinol (Oxf); 2008 Mar; 68(3):375-81. PubMed ID: 17877759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic Syndrome and Serum Liver Enzymes Level at Patients with Type 2 Diabetes Mellitus.
    Music M; Dervisevic A; Pepic E; Lepara O; Fajkic A; Ascic-Buturovic B; Tuna E
    Med Arch; 2015 Aug; 69(4):251-5. PubMed ID: 26543313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alanine aminotransferase and gamma-glutamyl transferase are associated with the metabolic syndrome but not with angiographically determined coronary atherosclerosis.
    Saely CH; Vonbank A; Rein P; Woess M; Beer S; Aczel S; Jankovic V; Boehnel C; Risch L; Drexel H
    Clin Chim Acta; 2008 Nov; 397(1-2):82-6. PubMed ID: 18708042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic covariation between serum gamma-glutamyltransferase activity and cardiovascular risk factors.
    Whitfield JB; Zhu G; Nestler JE; Heath AC; Martin NG
    Clin Chem; 2002 Sep; 48(9):1426-31. PubMed ID: 12194918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of a probiotic on liver aminotransferases in nonalcoholic fatty liver disease patients: a double blind randomized clinical trial.
    Aller R; De Luis DA; Izaola O; Conde R; Gonzalez Sagrado M; Primo D; De La Fuente B; Gonzalez J
    Eur Rev Med Pharmacol Sci; 2011 Sep; 15(9):1090-5. PubMed ID: 22013734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dulaglutide decreases plasma aminotransferases in people with Type 2 diabetes in a pattern consistent with liver fat reduction: a post hoc analysis of the AWARD programme.
    Cusi K; Sattar N; García-Pérez LE; Pavo I; Yu M; Robertson KE; Karanikas CA; Haupt A
    Diabet Med; 2018 Oct; 35(10):1434-1439. PubMed ID: 29869810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of elevated liver enzymes in Type 2 diabetes mellitus and its association with the metabolic syndrome.
    Forlani G; Di Bonito P; Mannucci E; Capaldo B; Genovese S; Orrasch M; Scaldaferri L; Di Bartolo P; Melandri P; Dei Cas A; Zavaroni I; Marchesini G
    J Endocrinol Invest; 2008 Feb; 31(2):146-52. PubMed ID: 18362506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of sustained decreases in sedentary time and increases in physical activity on liver enzymes and indices in type 2 diabetes.
    Haxhi J; Vitale M; Mattia L; Giuliani C; Sacchetti M; Orlando G; Iacobini C; Menini S; Zanuso S; Nicolucci A; Balducci S; Pugliese G
    Front Endocrinol (Lausanne); 2024; 15():1393859. PubMed ID: 38854689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver enzymes and risk of diabetes and cardiovascular disease: results of the Firenze Bagno a Ripoli (FIBAR) study.
    Monami M; Bardini G; Lamanna C; Pala L; Cresci B; Francesconi P; Buiatti E; Rotella CM; Mannucci E
    Metabolism; 2008 Mar; 57(3):387-92. PubMed ID: 18249212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple factors are required for the prediction of metabolic syndrome.
    Kawada T
    Clin Exp Pharmacol Physiol; 2011 Oct; 38(10):724; autohr reply 725. PubMed ID: 21711380
    [No Abstract]   [Full Text] [Related]  

  • 20. γ-glutamyl transpeptidase in men and alanine aminotransferase in women are the most suitable parameters among liver function tests for the prediction of metabolic syndrome in nonviral hepatitis and nonfatty liver in the elderly.
    Pei D; Hsia TL; Chao TT; Lin JD; Hsu CH; Wu CZ; Hsieh CH; Liang YJ; Chen YL
    Saudi J Gastroenterol; 2015; 21(3):158-64. PubMed ID: 26021775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.